Cargando…
Breast cancer heterogeneity and its implication in personalized precision therapy
Breast cancer heterogeneity determines cancer progression, treatment effects, and prognosis. However, the precise mechanism for this heterogeneity remains unknown owing to its complexity. Here, we summarize the origins of breast cancer heterogeneity and its influence on disease progression, recurren...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830930/ https://www.ncbi.nlm.nih.gov/pubmed/36624542 http://dx.doi.org/10.1186/s40164-022-00363-1 |
_version_ | 1784867766856056832 |
---|---|
author | Guo, Liantao Kong, Deguang Liu, Jianhua Zhan, Ling Luo, Lan Zheng, Weijie Zheng, Qingyuan Chen, Chuang Sun, Shengrong |
author_facet | Guo, Liantao Kong, Deguang Liu, Jianhua Zhan, Ling Luo, Lan Zheng, Weijie Zheng, Qingyuan Chen, Chuang Sun, Shengrong |
author_sort | Guo, Liantao |
collection | PubMed |
description | Breast cancer heterogeneity determines cancer progression, treatment effects, and prognosis. However, the precise mechanism for this heterogeneity remains unknown owing to its complexity. Here, we summarize the origins of breast cancer heterogeneity and its influence on disease progression, recurrence, and therapeutic resistance. We review the possible mechanisms of heterogeneity and the research methods used to analyze it. We also highlight the importance of cell interactions for the origins of breast cancer heterogeneity, which can be further categorized into cooperative and competitive interactions. Finally, we provide new insights into precise individual treatments based on heterogeneity. |
format | Online Article Text |
id | pubmed-9830930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-98309302023-01-11 Breast cancer heterogeneity and its implication in personalized precision therapy Guo, Liantao Kong, Deguang Liu, Jianhua Zhan, Ling Luo, Lan Zheng, Weijie Zheng, Qingyuan Chen, Chuang Sun, Shengrong Exp Hematol Oncol Review Breast cancer heterogeneity determines cancer progression, treatment effects, and prognosis. However, the precise mechanism for this heterogeneity remains unknown owing to its complexity. Here, we summarize the origins of breast cancer heterogeneity and its influence on disease progression, recurrence, and therapeutic resistance. We review the possible mechanisms of heterogeneity and the research methods used to analyze it. We also highlight the importance of cell interactions for the origins of breast cancer heterogeneity, which can be further categorized into cooperative and competitive interactions. Finally, we provide new insights into precise individual treatments based on heterogeneity. BioMed Central 2023-01-09 /pmc/articles/PMC9830930/ /pubmed/36624542 http://dx.doi.org/10.1186/s40164-022-00363-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Guo, Liantao Kong, Deguang Liu, Jianhua Zhan, Ling Luo, Lan Zheng, Weijie Zheng, Qingyuan Chen, Chuang Sun, Shengrong Breast cancer heterogeneity and its implication in personalized precision therapy |
title | Breast cancer heterogeneity and its implication in personalized precision therapy |
title_full | Breast cancer heterogeneity and its implication in personalized precision therapy |
title_fullStr | Breast cancer heterogeneity and its implication in personalized precision therapy |
title_full_unstemmed | Breast cancer heterogeneity and its implication in personalized precision therapy |
title_short | Breast cancer heterogeneity and its implication in personalized precision therapy |
title_sort | breast cancer heterogeneity and its implication in personalized precision therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830930/ https://www.ncbi.nlm.nih.gov/pubmed/36624542 http://dx.doi.org/10.1186/s40164-022-00363-1 |
work_keys_str_mv | AT guoliantao breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy AT kongdeguang breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy AT liujianhua breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy AT zhanling breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy AT luolan breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy AT zhengweijie breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy AT zhengqingyuan breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy AT chenchuang breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy AT sunshengrong breastcancerheterogeneityanditsimplicationinpersonalizedprecisiontherapy |